Our team is on a mission to make childhood cancer universally survivable!​

 Our mission is to translate scientific discovery into clinical trials by understanding and proving new disease-specific treatment options for children with cancer.This concept was emphasized in the Institute of Medicine Report, Making Better Drugs for Children with Cancer in 2005. cc-TDI now fills this crucially needed role created as a result of the ever-changing climate of federal funding for childhood cancer research.
Every year, the FDA approves on average 12 drugs to treat adult cancer, but has only approved 8 drugs to treat childhood cancer since 1978. Since our inception in 2015, cc-TDI has pushed two drugs into three clinical trials to treat childhood cancer.
BIG THANKS TO MEGAN BUGG!! CLICK HERE to support her legacy https://cc-tdi.kindful.com/honor-pages-2017/team-megan-bugg